馥感啉口服液治疗儿童流行性腮腺炎临床疗效观察

Efficacy of Fuganlin oral liquid on the treatment of children with epidemic mumps

目的 :探究分析馥感啉口服液治疗流行性腮腺炎的临床疗效。方法 :选取我院流行性腮腺炎患儿80例随机分为观察组(n=40,口服馥感啉口服液)和对照组(n=40,口服利巴韦林颗粒)。比较两组患儿用药3 d后临床疗效和症状缓解时间。结果 :观察组治疗后总有效率(95.0%)明显高于对照组(60.0%),且其退热时间、腮腺肿大消退时间等症状缓解时间也明显优于对照组(P<0.05)。结论 :馥感啉口服液相较于常规应用利巴韦林治疗对流行性腮腺炎效果明显,临床症状缓解时间良好。

Objective： To investigate the efficacy of Fuganlin oral liquid on the treatment of children with epidemic mumps. Methods： Eighty children with epidemic mumps in our hospital were randomly divided into an observation group（n=40, received Fuganlin oral liquid） and a control group（n=40, received ribavirin granules）. The clinical efficacy and the time for symptom relief were compared between two groups 3 days after the treatment. Results： The total efficiency of the observation group（95.0%） was significantly higher than that of the control group（60.0%）. The symptom relief such as the defervesce time and the parotid swelling subsided was also significantly better in the observation group than in the control group（P0.05）. Conclusion： Fuganlin oral liquid has better efficacy and is much better for the relief of clinical symptom than ribavirin granules in the treatment of epidemic mumps.